Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2010 / Cilt: 44 - Sayı: 3

Neonatal abstinence syndrome

Neonatal yoksunluk sendromu

Pages
124–127
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article presented with neonatal abstinence syndrome detected by a dependent mother’s baby heroin use during pregnancy period.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neonatal abstinence syndrome is characterized by a clinical situation with withdrawal symptoms and physical dependence in the uterus exposed to addictive substances in infants.
📊
Key Findings & Data:The prevalence of neonatal abstinence syndrome is between 16-90% in infants of mothers who used heroin.
💡
Conclusion & Impact:In this article presented with neonatal abstinence syndrome detected by a dependent mother’s baby heroin use during pregnancy period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neonatal abstinence syndrome is characterized by a clinical situation with withdrawal symptoms and physical dependence in the uterus exposed to addictive substances in infants. The well-known method in diagnosis of neonatal abstinence syndrome is to identify addictive substances in the first meconium. The prevalence of neonatal abstinence syndrome is between 16-90% in infants of mothers who used heroin. Clinical findings often occur within the first 48-72 hours. Most obvious symptoms are tremor and hiperirritability. Neonatal central nervous system is most common affected. Gastrointestinal system creates a second often affected. Mortality associated with premature birth problems, infections and perinatal asphyxia. This syndrome should be treated when it were convulsions, diarrhea, sleep and diet in the presence of the distorting extreme deprivation syndrome. Treatment of the syndrome were important by opium, benzodiazepines, phenobarbital with calm and quiet environment and to minimize the stimulus into newborn. In this article presented with neonatal abstinence syndrome detected by a dependent mother’s baby heroin use during pregnancy period.

Özet

Neonatal yoksunluk sendromu, uterus içinde bağımlılık yapan maddeye maruz kalmış infantlarda çekilme semptomlarıyla ve fiziksel bağımlılıkla karakterize klinik bir durumdur. En iyi tanı metodu bebeğin ilk mekonyumunda bağımlılık yapan maddenin saptanmasıdır. Eroin kullanan annelerin bebeklerinde neonatal yoksunluk sendromunun görülme sıklığı %16-90’dır. Klinik bulgular sıklıkla ilk 48-72 saat içerisinde ortaya çıkmaktadır. Tremor ve hiperirritabilite en belirgin bulgulardır. Yenidoğanda en sık merkezi sinir sistemi ve gastrointestinal sistem etkilenmektedir. Mortalite; sıklıkla eşlik eden erken doğum sorunları, enfeksiyon ve perinatal asfiksi ile ilişkilidir. Konvülziyon, ishal, uyku ve beslenme düzenini bozan hiperirritabilite varlığında yoksunluk sendromu tedavi edilmelidir. Tedavide opiatlar, benzodiazepinler, fenobarbital ile birlikte yenidoğanın sakin ve sessiz bir ortama alınması ve uyaranların minimuma indirilmesi önemlidir. Bu yazıda gebelik dönemi süresince eroin kullanan bağımlı bir annenin, bebeğinde saptanan neonatal yoksunluk sendromu olgusu sunulmuştur.

🔖

Cite This Article

CAN, E., BÜLBÜL, A., USLU, S., GÜRAN, Ö., NUHOĞLU, A. (2010). Neonatal abstinence syndrome. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 44 - Sayı: 3, 124–127. https://ajindex.com/articles/364114

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kalyoncu A. Eroin Bağımlılığı. Türkiye Klinikleri J Int Med Sci 2005;1:79-88. 2 Sherwood RA, Keating J, Kavvadia V, Greenough A, Peters TJ. Substance misuse in early pregnancy and relationship to fetal outcome. Eur J Pediatr 1999;158:488-492. 3. Boer K, Smit BJ, Vanhuis AM, Hogerzeil HV. Substance use in pregnancy—do we care? Acta Paediatrica Suppl 1994;404:65- 71. 4. Hulse GK, Milne E, English DR, Holman CDJ. Assessing the relationship between maternal opiate use and neonatal mortality. Addiction 1998;93:1033-1042. 5. Hulse GK, Milne E, English DR, Holman CDJ. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997;92:1571-1579. 6. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn and young child. Int J Addict 1993;28:1341-1391. 7. Sinha C, Ohadike P, Carrick P, Pairaudeau P, Armstrong D, Lindow SW. Neonatal outcome following maternal opiate use in late pregnancy. Int J Obstet Gynaecol 2001;74:241-246. 8. Kuschel C. Managing drug withdrawal in the newborn infant. Seminars in Fetal & Neonatal Medicine 2007;12:127-133. 9. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006;117:1163-1169. 10. Ostrea EM Jr. Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis. Curr Probl Pediatr 1999;29:37-56. 11. Lainwala S, Brown ER, Weinschenk NP, Blackwell MT, Hagadorn JI. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations. Adv NeonatalCare 2005;5:265-272. 12. Okan F, Bulbul A, Nuhoglu A. Gebelikte madde suistimali. Çocuk Dergisi 2007;7:76-80.